Trafalgar International (GCAN) Cash from Investing Activities (2020)
Greater Cannabis Company (GCAN) posted quarterly Cash from Investing Activities of -$36750.0 for Q4 2020, down 47.0% quarter-over-quarter from -$25000.0 in Q1 2020.
Trafalgar International (GCAN) Cash from Investing Activities (2020) Analysis & Trends
Greater Cannabis Company's Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$36750.0 for Q4 2020.
- In Q4 2020, Cash from Investing Activities changed N/A year-over-year to -$36750.0; the TTM figure through Dec 2020 stood at -$61750.0 (changed N/A YoY), while the FY2020 annual figure was -$61750.0, changed N/A from the prior year.
- Cash from Investing Activities for Q4 2020 stood at -$36750.0, down from -$25000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$25000.0 in Q1 2020, with the low at -$36750.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -36,750.00 |
| Dec 31, 2020 | -36,750.00 |
| Mar 31, 2020 | -25,000.00 |
| Mar 31, 2020 | -25,000.00 |